Net Income

Merchants Bancorp declared its Q2 dividends, underscoring financial health. The move comes as the bank navigates a complex market and legal scrutiny.

MedX Holdings rebrands to Dazed Inc., launching a multi-city expansion and new coffee line to capitalize on cannabis's landmark move to Schedule III.

MNTN's CEO faces investors at two key June conferences. Amid record profits and a competitive market, the stakes are high for the CTV ad-tech firm.

CIBC settles a class action over mutual fund fees. Learn if you're eligible for a payout and what this means for investor rights in Canada.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

FortuneX Acquisition Corp. raised $75M in its IPO, but it enters a SPAC market wary of past failures and facing stricter regulatory oversight.

Quanex will report Q2 results on June 4, with investors watching for updates on its Tyman integration and performance in a tough building market.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

After unprecedented growth, Clear Fork Bank names a new CEO known for community ties, signaling a strategy to blend legacy values with future expansion.

NewGenIVF, a firm with roots in fertility and facing financial headwinds, is investing in a $100M AI startup. Is it a visionary pivot or a risky gamble?

KPET Ultra Paceline's unit split offers investor flexibility, but what does it signal about the SPAC's hunt for a deal in a changed market?

Dream Finders Homes escalates its takeover attempt of Beazer Homes with a public offer, citing a decade of underperformance and a failing strategy.

The electronics giant reports lower revenue and profit for FY2026, citing tariffs and global uncertainty, yet boosts margins and bets on innovation.

The private markets giant announced a dividend hike and expanded buyback after a stellar fiscal year, crossing the $1 trillion asset milestone.

As X Financial prepares its Q1 2026 results, investors are watching closely after a tough Q4 and amid China's harsh new fintech regulations.

The photonic quantum firm gets flexible funding to scale its tech, but investors must weigh the promise of growth against the risk of stock dilution.

After a record 2025, investors are watching if UP Fintech can sustain its growth amid global market turmoil and rising interest rates.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

The acquisition creates a $7.6B regional powerhouse, sparking questions about the future of community banking for customers, employees, and competitors.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.